Amin, N. E., Giske, C. G., Jalal, S., Keijser, B., Kronvall, G., & Wretlind, B. (2005). Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates. Apmis, 113(3), 187-196.
Chalhoub, H., Sáenz, Y., Rodriguez-Villalobos, H., Denis, O., Kahl, B. C., Tulkens, P. M., & Van Bambeke, F. (2016). High-level resistance to meropenem in clinical isolates of Pseudomonas aeruginosa in the absence of carbapenemases: role of active efflux and porin alterations. International journal of antimicrobial agents, 48(6), 740-743.
Cowan, S., Schirmer, T., Rummel, G., Steiert, M., Ghosh, R., Pauptit, R., . . . Rosenbusch, J. (1992). Crystal structures explain functional properties of two E. coli porins. Nature, 358(6389), 727.
Dantas, R. C. C., e Silva, R. T., Ferreira, M. L., Gonçalves, I. R., Araújo, B. F., de Campos, P. A., . . . Ribas, R. M. (2017). Molecular epidemiological survey of bacteremia by multidrug resistant Pseudomonas aeruginosa: the relevance of intrinsic resistance mechanisms. PloS one, 12(5), e0176774.
Dubois, V., Arpin, C., Dupart, V., Scavelli, A., Coulange, L., André, C., . . . Lagrange, I. (2008). β-Lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres). Journal of Antimicrobial Chemotherapy, 62(2), 316-323.
Fournier, D., Richardot, C., Müller, E., Robert-Nicoud, M., Llanes, C., Plésiat, P., & Jeannot, K. (2013). Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy, 68(8), 1772-1780.
Gill, M. M., Usman, J., Kaleem, F., Hassan, A., Khalid, A., Anjum, R., & Fahim, Q. (2011). Frequency and antibiogram of multi-drug resistant Pseudomonas aeruginosa. J Coll Physicians Surg Pak, 21(9), 531-534.
Gutiérrez, O., Juan, C., Cercenado, E., Navarro, F., Bouza, E., Coll, P., . . . Oliver, A. (2007). Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals. Antimicrobial agents and chemotherapy, 51(12), 4329-4335.
Hammami, S., Ghozzi, R., Burghoffer, B., Arlet, G., & Redjeb, S. (2009). Mechanisms of carbapenem resistance in non-metallo-β-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathologie Biologie, 57(7-8), 530-535.
Hancock, R. E., & Brinkman, F. S. (2002). Function of Pseudomonas porins in uptake and efflux. Annual Reviews in Microbiology, 56(1), 17-38.
Hirabayashi, A., Kato, D., Tomita, Y., Iguchi, M., Yamada, K., Kouyama, Y., . . . Yagi, T. (2017). Risk factors for and role of OprD protein in increasing minimal inhibitory concentrations of carbapenems in clinical isolates of Pseudomonas aeruginosa. Journal of medical microbiology, 66(11), 1562-1572.
Huang, H., Jeanteur, D., Pattus, F., & Hancock, R. E. (1995). Membrane topology and site-specific mutagenesis of Pseudomonas aeruginosa porin OprD. Mol Microbiol, 16(5), 931-941. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7476190
Kohanteb, J., Dayaghi, M., Motazedian, M., & Ghayumi, M.-A. (2007). Comparison of biotyping and antibiotyping of Pseudomonas aeruginosa isolated from patients with burn wound infection and nosocomial pneumonia in Shiraz, Iran. Pakistan journal of biological sciences: PJBS, 10(11), 1817-1822.
Lei, Y., Wang, H., Sun, Z., & Shen, Z. (2003). Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones. Zhonghua yi xue za zhi, 83(5), 403-407.
Levine, C., Hiasa, H., & Marians, K. J. (1998). DNA gyrase and topoisomerase IV: biochemical activities, physiological roles during chromosome replication, and drug sensitivities. Biochimica et Biophysica Acta (BBA)-Gene Structure and Expression, 1400(1-3), 29-43.
Lister, P. D., Wolter, D. J., & Hanson, N. D. (2009). Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clinical microbiology reviews, 22(4), 582-610.
Lynch, M., Drusano, G., & Mobley, H. (1987). Emergence of resistance to imipenem in Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 31(12), 1892-1896.
Ocampo-Sosa, A. A., Cabot, G., Rodríguez, C., Roman, E., Tubau, F., Macia, M. D., . . . Peña, C. (2012). Alterations of OprD in carbapenem-intermediate and-susceptible strains of Pseudomonas aeruginosa isolated from bacteremia in a Spanish multicenter study. Antimicrobial agents and chemotherapy, AAC. 05451-05411.
Pirnay, J. P., Vos, D. D., Mossialos, D., Vanderkelen, A., Cornelis, P., & Zizi, M. (2002). Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environmental microbiology, 4(12), 872-882.
Riera, E., Cabot, G., Mulet, X., García-Castillo, M., del Campo, R., Juan, C., . . . Oliver, A. (2011). Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem. Journal of Antimicrobial Chemotherapy, 66(9), 2022-2027.
Rostami, S., Sheikh, A. F., Shoja, S., Farahani, A., Tabatabaiefar, M. A., Jolodar, A., & Sheikhi, R. (2018). Investigating of four main carbapenem-resistance mechanisms in high-level carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Journal of the Chinese Medical Association, 81(2), 127-132.
Sanbongi, Y., Shimizu, A., Suzuki, T., Nagaso, H., Ida, T., Maebashi, K., & Gotoh, N. (2009). Classification of OprD sequence and correlation with antimicrobial activity of carbapenem agents in Pseudomonas aeruginosa clinical isolates collected in Japan. Microbiology and immunology, 53(7), 361-367.
Sapino, B., Mazzucato, S., Solinas, M., Gion, M., & Grandesso, S. (2012). Comparison of different methods for determining beta-lactam susceptibility in Pseudomonas aeruginosa. Microbiologica-Quarterly Journal of Microbiological Sciences, 35(4), 491.
Shen, J., Pan, Y., & Fang, Y. (2015). Role of the outer membrane protein OprD2 in carbapenem-resistance mechanisms of Pseudomonas aeruginosa. PloS one, 10(10), e0139995.
Sun, Q., Ba, Z., Wu, G., Wang, W., Lin, S., & Yang, H. (2016). Insertion sequence ISRP10 inactivation of the oprD gene in imipenem-resistant Pseudomonas aeruginosa clinical isolates. International journal of antimicrobial agents, 47(5), 375-379.
Wolter, D. J., Hanson, N. D., & Lister, P. D. (2004). Insertional inactivation of opr D in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS microbiology letters, 236(1), 137-143.
Yan, Y., Yao, X., Li, H., Zhou, Z., Huang, W., Stratton, C. W., . . . Tang, Y.-W. (2014). A novel oprD-mutated Pseudomonas aeruginosa strain in relation to a nosocomial respiratory infection outbreak in an intensive care unit. Journal of clinical microbiology, JCM. 02782-02714.
Yoneyama, H., & Nakae, T. (1993). Mechanism of efficient elimination of protein D2 in outer membrane of imipenem-resistant Pseudomonas aeruginosa. Antimicrobial agents and chemotherapy, 37(11), 2385-2390.
Zarei-Yazdeli, M., Eslami, G., Zandi, H., Mousavi, S. M., Kosha, H., Akhavan, F., & Kiani, M. (2014). Relationship between antimicrobial resistance and class I integron in Pseudomonas aeruginosa isolated from clinical specimens in Yazd during 2012-2013. Feyz Journal of Kashan University of Medical Sciences, 18(1).